title: Intranasal administration of PEGylated transforming growth factor-alpha improves behavioral deficits in a chronic stroke model.
abstract: We previously demonstrated that infusion of transforming growth factor (TGF)-alpha after chronic middle cerebral artery occlusion (MCAO) stimulates stem and progenitor cell proliferation, migration, and neuronal differentiation associated with the amelioration of neurologic impairment. But the use of TGF-alpha in humans is impeded by impracticality of intracranial infusion and the inability of intravenous TGF-alpha to cross the blood-brain barrier. Here we investigated whether intranasal delivery of PEGylated TGF-alpha (PEG-TGF-alpha) is a viable alternative. We found that intranasal PEG-TGF-alpha can also induce the proliferation of neural progenitors and their migration to the damaged striatum, and that this is associated with significant behavioral improvement in the MCAO model. This nonsurgical approach represents a potential therapeutic strategy for human patients.
authors.affiliation: Department of Anatomy and Neurobiology, University of California Irvine, Irvine, California 92697, USA. magdagmx@hotmail.com
authors.forename: Magda
authors.initials: M
authors.lastname: Guerra-Crespo
authors.forename: Andres
authors.initials: A
authors.lastname: Sistos
authors.forename: Darius
authors.initials: D
authors.lastname: Gleason
authors.forename: James H
authors.initials: JH
authors.lastname: Fallon
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D004195:Disease Models, Animal; D004337:Drug Carriers; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D009043:Motor Activity / Q000187:drug effects*; D055495:Neurogenesis / Q000187:drug effects; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D011092:Polyethylene Glycols / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020127:Recovery of Function; D013234:Stem Cells / Q000187:drug effects / Q000473:pathology; D013997:Time Factors; D016211:Transforming Growth Factor alpha / Q000008:administration & dosage* / Q000737:chemistry
chemical_list: D004337:Drug Carriers; D016211:Transforming Growth Factor alpha; D011092:Polyethylene Glycols